Managing Congestive Heart Failure in Dogs: Quality of Life

Congestive heart failure in dogs is manageable with modern medications, and quality of life can remain good for months to years with appropriate treatment.

Key Facts

CHF in dogs results most commonly from myxomatous mitral valve disease or dilated cardiomyopathy
Treatment includes furosemide, pimobendan, ACE inhibitors, and spironolactone
Home respiratory rate monitoring is the most reliable early warning sign of decompensation
Resting respiratory rate above 30 breaths per minute signals increasing fluid accumulation
Dietary sodium restriction provides modest benefit but palatability must be maintained
Activity restriction reduces cardiac workload during decompensation episodes
Regular monitoring with chest radiographs and echocardiography guides medication adjustment

Welfare Considerations

CHF causes significant suffering when poorly controlled - dyspnea (difficulty breathing) is one of the most distressing experiences for any animal. However, with modern medication protocols, many dogs with CHF remain comfortable and engaged for extended periods. The welfare key is monitoring resting respiratory rate as a home early warning system - owners who catch decompensation early and adjust medications promptly prevent acute respiratory crises. End-of-life decisions should be guided by quality of life assessment rather than a specific diagnosis.

What You Can Do

Learn to measure resting respiratory rate and monitor it daily at home
Seek same-day veterinary care if resting respiratory rate exceeds 30 breaths per minute
Administer all cardiac medications consistently - skipping doses risks rapid decompensation
Schedule regular rechecks (every 3-6 months) to adjust medications as disease progresses
Use quality of life tools to guide honest end-of-life decision making